Odile Launay

Odile Launay's AcademicInfluence.com Rankings

Odile Launay

Biology

#12330

World Rank

#15800

Historical Rank

Virology

#299

World Rank

#306

Historical Rank

Cell Biology

#647

World Rank

#661

Historical Rank

Immunology

#821

World Rank

#844

Historical Rank

biology Degrees

Download Badge

Biology

Odile Launay's Degrees

PhD Biomedical Sciences Université Paris Cité

Why Is Odile Launay Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Odile Launay's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial (2006) (418)
A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation (2020) (398)
Determinants of Disease Presentation and Outcome during Cryptococcosis: The CryptoA/D Study (2007) (357)
Tuberculosis in HIV-infected patients: a comprehensive review. (2004) (343)
Vaccine Hesitancy Among General Practitioners and Its Determinants During Controversies: A National Cross-sectional Survey in France (2015) (258)
The French public's attitudes to a future COVID-19 vaccine: The politicization of a public health issue (2020) (248)
Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19 (2022) (212)
Mucosal Imprinting of Vaccine-Induced CD8+ T Cells Is Crucial to Inhibit the Growth of Mucosal Tumors (2013) (209)
2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1) pdm09 and B among elderly people in Europe: results from the I-MOVE plus project (2017) (183)
Respiratory Syncytial Virus and Other Respiratory Viral Infections in Older Adults With Moderate to Severe Influenza-like Illness (2014) (177)
Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial. (2011) (170)
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial (2021) (168)
Knowledge, attitudes and vaccination coverage of healthcare workers regarding occupational vaccinations. (2009) (152)
AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial. (2013) (150)
Gag Mutations Strongly Contribute to HIV-1 Resistance to Protease Inhibitors in Highly Drug-Experienced Patients besides Compensating for Fitness Loss (2009) (147)
Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients (2008) (143)
Patient perspective on herpes zoster and its complications: An observational prospective study in patients aged over 50years in general practice (2012) (135)
Long-term immune responses to vaccination in HIV-infected patients: a systematic review and meta-analysis. (2014) (129)
Cryptococcal Neuroradiological Lesions Correlate with Severity during Cryptococcal Meningoencephalitis in HIV-Positive Patients in the HAART Era (2008) (106)
CD4 T Cells with Effector Memory Phenotype and Function Develop in the Sterile Environment of the Fetus (2014) (106)
Autoimmune diseases in HIV-infected patients: 52 cases and literature review. (2014) (99)
Pivotal role of M-DC8⁺ monocytes from viremic HIV-infected patients in TNFα overproduction in response to microbial products. (2012) (96)
French Experience of 2009 A/H1N1v Influenza in Pregnant Women (2010) (95)
Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study. (2012) (95)
The changing clinical aspects of infective endocarditis: descriptive review of 90 episodes in a French teaching hospital and risk factors for death. (2002) (94)
A report on the status of vaccination in Europe. (2018) (92)
Low rate of influenza and pneumococcal vaccine coverage in rheumatoid arthritis: data from the international COMORA cohort. (2015) (91)
Attitude, knowledge and factors associated with influenza and pneumococcal vaccine uptake in a large cohort of patients with secondary immune deficiency. (2015) (82)
Vaccine Education of Medical Students: A Nationwide Cross-sectional Survey. (2017) (81)
Low influenza vaccination rate among patients receiving chemotherapy for cancer. (2008) (78)
Cohort Profile: French hospital database on HIV (FHDH-ANRS CO4). (2014) (74)
Prevention of infections during primary immunodeficiency. (2014) (71)
Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial (2018) (71)
Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: A placebo-controlled trial (2009) (70)
Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe (2017) (68)
TNF alpha antagonist therapy and safety monitoring. (2011) (68)
Determinants of Non-Vaccination against Pandemic 2009 H1N1 Influenza in Pregnant Women: A Prospective Cohort Study (2011) (67)
Hepatitis B and human immunodeficiency virus co-infection. (2014) (66)
Low influenza-vaccination rate among adults receiving immunosuppressive therapy for systemic inflammatory disease (2006) (66)
Factors associated with vaccination for hepatitis B, pertussis, seasonal and pandemic influenza among French general practitioners: a 2010 survey. (2013) (65)
Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review (2021) (65)
Maternal Immune Response and Neonatal Seroprotection From a Single Dose of a Monovalent Nonadjuvanted 2009 Influenza A(H1N1) Vaccine (2011) (64)
Immunological Efficacy of a Three-Dose Schedule of Hepatitis A Vaccine in HIV-Infected Adults: HEPAVAC Study (2008) (64)
Immunogenicity and safety of the influenza A H1N1v 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE study. (2012) (64)
Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial. (2020) (62)
Clinical safety of HIV lipopeptides used as vaccines in healthy volunteers and HIV-infected adults (2006) (57)
Impact of Late Presentation on the Risk of Death Among HIV-Infected People in France (2003–2009) (2013) (57)
PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study. (2020) (56)
Does monastic life predispose to the risk of Saint Anthony's fire (herpes zoster)? (2011) (55)
Factors associated with poor outcomes among adults hospitalized for influenza in France: A three-year prospective multicenter study. (2016) (54)
Quantification of seven nucleoside/nucleotide reverse transcriptase inhibitors in human plasma by high-performance liquid chromatography with tandem mass-spectrometry. (2008) (54)
Antibodies to tetanus, diphtheria and pertussis among healthy adults vaccinated according to the French vaccination recommendations (2009) (54)
Zinc transporter (ZnT)8186–194 is an immunodominant CD8+ T cell epitope in HLA-A2+ type 1 diabetic patients (2012) (53)
Global Perspectives on Immunization During Pregnancy and Priorities for Future Research and Development: An International Consensus Statement (2020) (53)
Clinical characteristics and outcome of respiratory syncytial virus infection among adults hospitalized with influenza-like illness in France (2016) (52)
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19 (2021) (52)
Candidemia: a nosocomial complication in adults with late-stage AIDS. (1998) (51)
Online mis/disinformation and vaccine hesitancy in the era of COVID-19: Why we need an eHealth literacy revolution (2021) (50)
COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study (2021) (49)
Quantification of darunavir (TMC114) in human plasma by high-performance liquid chromatography with ultra-violet detection. (2007) (49)
Adherence to preventive measures after splenectomy in the hospital setting and in the community. (2011) (47)
Glycosidic Tn-based vaccines targeting dermal dendritic cells favor germinal center B-cell development and potent antibody response in the absence of adjuvant. (2010) (47)
Pregnancy-Related Effects on Tenofovir Pharmacokinetics: a Population Study with 186 Women (2011) (46)
Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trial (2010) (46)
Safety and immunogenicity of a monovalent 2009 influenza A/H1N1v vaccine adjuvanted with AS03A or unadjuvanted in HIV-infected adults: a randomized, controlled trial. (2011) (45)
Vaccinations among medical and nursing students: coverage and opportunities. (2014) (45)
Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: results from the FHDH-ANRS CO4 cohort. (2015) (44)
Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial. (2015) (44)
Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patients. (2012) (44)
Absence of association between MDR1 genetic polymorphisms, indinavir pharmacokinetics and response to highly active antiretroviral therapy (2005) (43)
Pregnancy outcomes in women with HIV type-1 receiving a lopinavir/ritonavir-containing regimen (2008) (42)
Dectin-1 activation unlocks IL12A expression and reveals the TH1 potency of neonatal dendritic cells. (2015) (42)
Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with GLA-SE or Alhydrogel® in European and African adults: A phase 1a/1b, randomized, double-blind multi-centre trial. (2017) (41)
Pregnancy-Related Effects on Lamivudine Pharmacokinetics in a Population Study with 228 Women (2011) (40)
First-year results of the Global Influenza Hospital Surveillance Network: 2012–2013 Northern hemisphere influenza season (2014) (40)
Hemagglutination Inhibition Antibody Titers as a Correlate of Protection Against Seasonal A/H3N2 Influenza Disease (2015) (40)
Phase I study of a candidate vaccine based on recombinant HIV-1 gp160 (MN/LAI) administered by the mucosal route to HIV-seronegative volunteers: the ANRS VAC14 study. (2008) (40)
Immunogenicity and Safety of Influenza Vaccine in Inflammatory Bowel Disease Patients Treated or not with Immunomodulators and/or Biologics: A Two-year Prospective Study. (2015) (39)
The French health pass holds lessons for mandatory COVID-19 vaccination (2022) (39)
Booster Vaccination With GVGH Shigella sonnei 1790GAHB GMMA Vaccine Compared to Single Vaccination in Unvaccinated Healthy European Adults: Results From a Phase 1 Clinical Trial (2019) (39)
Determinants of Refusal of A/H1N1 Pandemic Vaccination in a High Risk Population: A Qualitative Approach (2012) (38)
Cellular Immune Responses Induced with Dose-Sparing Intradermal Administration of HIV Vaccine to HIV-Uninfected Volunteers in the ANRS VAC16 Trial (2007) (37)
Persistence of Yellow Fever Vaccine–Induced Antibodies After Solid Organ Transplantation (2013) (37)
Failure of the vaccination campaign against A(H1N1) influenza in pregnant women in France: results from a national survey. (2012) (37)
Residual HIV-1 RNA and HIV-1 Dna Production in the Genital Tract Reservoir of Women Treated with Haart: The Prospective Anrs Ep24 Gynodyn Study (2011) (37)
Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: results of a Phase 2, randomized, double-blind placebo-controlled trial. (2009) (37)
Characteristics of patients and physicians correlated with regular influenza vaccination in patients treated for type 2 diabetes: a follow-up study from 2008 to 2011 in southeastern France. (2015) (35)
Vaccine coverage of healthcare students in hospitals of the Paris region in 2009: the Studyvax survey. (2013) (35)
2011–12 Seasonal Influenza Vaccines Effectiveness against Confirmed A(H3N2) Influenza Hospitalisation: Pooled Analysis from a European Network of Hospitals. A Pilot Study (2013) (34)
Significant reduction in HIV virologic failure during a 15-year period in a setting with free healthcare access. (2015) (34)
High levels of serum hepatitis B virus DNA in patients with ‘anti‐HBc alone’: role of HBsAg mutants (2011) (34)
Poor sleep associated with overuse of media during the COVID-19 lockdown (2020) (33)
Seasonal influenza vaccine uptake and vaccine refusal among pregnant women in France: results from a national survey (2019) (33)
Safety and Immunogenicity of Yellow Fever 17D Vaccine in Adults Receiving Systemic Corticosteroid Therapy: An Observational Cohort Study (2013) (33)
Knowledge, attitudes, beliefs and behaviors of general practitioners/family physicians toward their own vaccination: A systematic review (2016) (33)
Efficacy and Tolerability of a Nucleoside Reverse Transcriptase Inhibitor-Sparing Combination of Lopinavir/Ritonavir and Efavirenz in HIV-1-Infected Patients (2005) (33)
Neonatal Plasmacytoid Dendritic Cells (pDCs) Display Subset Variation but Can Elicit Potent Anti-Viral Innate Responses (2013) (33)
Pandemic Influenza (A/H1N1) Vaccine Uptake among French Private General Practitioners: A Cross Sectional Study in 2010 (2012) (32)
2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals. (2015) (32)
Bacterial prostatitis due to Pseudomonas aeruginosa harbouring the blaVIM-2 metallo-{beta}-lactamase gene from Saudi Arabia. (2005) (32)
2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: results from the I-MOVE+ project (2017) (32)
Prognostic Factors in Syphilitic Uveitis. (2017) (31)
Long-term Immune Response to Hepatitis B Virus Vaccination Regimens in Adults With Human Immunodeficiency Virus 1: Secondary Analysis of a Randomized Clinical Trial. (2016) (31)
2012-2013 Seasonal Influenza Vaccine Effectiveness against Influenza Hospitalizations: Results from the Global Influenza Hospital Surveillance Network (2014) (31)
Measles immunity and measles vaccine acceptance among healthcare workers in Paris, France. (2013) (30)
Pneumococcal vaccination in patients with systemic lupus erythematosus: A multicenter placebo-controlled randomized double-blind study. (2017) (30)
Influenza during pregnancy: Incidence, vaccination coverage and attitudes toward vaccination in the French web-based cohort G-GrippeNet. (2016) (30)
Would we recover better sleep at the end of Covid-19? A relative improvement observed at the population level with the end of the lockdown in France (2020) (30)
Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 season (2017) (30)
Knowledge, attitudes, beliefs and practices of general practitioners towards measles and MMR vaccination in southeastern France in 2012. (2014) (29)
Low Rate of Pandemic A/H1N1 2009 Influenza Infection and Lack of Severe Complication of Vaccination in Pregnant Women: A Prospective Cohort Study (2012) (29)
Impaired sperm motility in HIV-infected men: an unexpected adverse effect of efavirenz? (2015) (29)
CD4+ cell count recovery after combined antiretroviral therapy in the modern combined antiretroviral therapy era (2018) (28)
Boosted protease inhibitor monotherapy as a maintenance strategy: an observational study (2012) (27)
Vaccinations : attitudes et pratiques des médecins généralistes (2015) (27)
Pneumococcal and influenza vaccine uptake in adults with inflammatory bowel disease in France: Results from a web-based study. (2018) (27)
Population analysis of the pregnancy-related modifications in lopinavir pharmacokinetics and their possible consequences for dose adjustment. (2009) (27)
Typhoid fever due to a Salmonella typhi strain of reduced susceptibility to fluoroquinolones. (1997) (26)
Plasmacytoid dendritic cells engagement by influenza vaccine as a surrogate strategy for driving T-helper type 1 responses in human neonatal settings. (2014) (26)
Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic Review (2016) (26)
Vaccination Against Hepatitis B Virus (HBV) in HIV-1-Infected Patients With Isolated Anti-HBV Core Antibody: The ANRS HB EP03 CISOVAC Prospective Study. (2016) (25)
Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza. (2017) (25)
Pandemic influenza A (H1N1) in pregnant women: impact of early diagnosis and antiviral treatment (2010) (25)
[History and principles of vaccination]. (2019) (25)
Influenza symptoms and their impact on elderly adults: randomised trial of AS03-adjuvanted or non-adjuvanted inactivated trivalent seasonal influenza vaccines (2014) (25)
Risk of Kaposi sarcoma during the first months on combination antiretroviral therapy (2013) (25)
Microbiota-based markers predictive of development of Clostridioides difficile infection (2021) (25)
Efficacy of COVID-19 vaccines: From clinical trials to real life (2021) (24)
Decreased ovarian reserve in HIV-infected women (2016) (24)
Why actively promote vaccination in patients with cirrhosis? (2009) (24)
Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial. (2020) (24)
Vaccines for healthcare-associated infections: present, future, and expectations (2018) (23)
A highly virulent variant of HIV-1 circulating in the Netherlands (2022) (23)
Effect of sublingual administration of interferon-alpha on the immune response to influenza vaccination in institutionalized elderly individuals. (2008) (23)
Low immunogenicity of seasonal trivalent influenza vaccine among patients receiving docetaxel for a solid tumour: results of a prospective pilot study (2011) (23)
Assessment of cetirizine, an antihistamine, to prevent cutaneous reactions to nevirapine therapy: results of the viramune-zyrtec double-blind, placebo-controlled trial. (2004) (23)
Long-Term Persistence of Humoral Immunity After Hepatitis A Vaccination in HIV-Infected Adults (2011) (22)
Public opinion on a mandatory COVID-19 vaccination policy in France: a cross-sectional survey (2021) (22)
Innate gene signature distinguishes humoral versus cytotoxic responses to influenza vaccination. (2019) (22)
Short communication: Long-term persistence of vaccine-induced HIV seropositivity among healthy volunteers. (2008) (22)
Longitudinal and Integrative Biomodeling of Effector and Memory Immune Compartments after Inactivated Influenza Vaccination (2013) (21)
Complicated hospitalization due to influenza: results from the Global Hospital Influenza Network for the 2017–2018 season (2020) (21)
Nodular lesions of the liver revealing multiple myeloma. (1999) (21)
Long-term immunogenicity of two doses of 2009 A/H1N1v vaccine with and without AS03A adjuvant in HIV-1-infected adults (2013) (20)
Differential Diffusions of Indinavir and Lopinavir in Genital Secretions of Human Immunodeficiency Virus-Infected Women (2004) (20)
Pharmacogenetics of toxicity, plasma trough concentration and treatment outcome with nevirapine-containing regimen in anti-retroviral-naïve HIV-infected adults: an exploratory study of the TRIANON ANRS 081 trial. (2011) (20)
Contribution of Cellular HIV-1 DNA Quantification to the Efficacy Analysis of Antiretroviral Therapy: A Randomized Comparison of 2 Regimens, Including 3 Drugs From 2 or 3 Classes (TRIANON, ANRS 081) (2005) (20)
Vaccination in adults with auto-immune disease and/or drug related immune deficiency: results of the GEVACCIM Delphi survey. (2009) (20)
Assessment of spread of SARS-CoV-2 by RT-PCR and concomitant serology in children in a region heavily affected by COVID-19 pandemic (2020) (20)
LB5. PROVENT: Phase 3 Study of Efficacy and Safety of AZD7442 (Tixagevimab/Cilgavimab) for Pre-exposure Prophylaxis of COVID-19 in Adults (2021) (20)
Clinical validation of IFNγ/IL-10 and IFNγ/IL-2 FluoroSpot assays for the detection of Tr1 T cells and influenza vaccine monitoring in humans (2014) (20)
Non-influenza respiratory viruses in adult patients admitted with influenza-like illness: a 3-year prospective multicenter study (2020) (20)
Control of humoral immunity and auto-immunity by the CXCR4/CXCL12 axis in lupus patients following influenza vaccine. (2013) (19)
HLA-B7–Restricted Islet Epitopes Are Differentially Recognized in Type 1 Diabetic Children and Adults and Form Weak Peptide-HLA Complexes (2012) (19)
Low immunogenicity of quadrivalent meningococcal vaccines in solid organ transplant recipients (2015) (19)
Should expectant mothers be vaccinated against flu? A safety review (2014) (19)
No detection of HIV 1-RNA in semen of men on efficient HAART in the past 4 years of a 2002–2009 survey (2010) (19)
Diphtheria, tetanus, poliomyelitis, yellow fever and hepatitis B seroprevalence among HIV1-infected migrants. Results from the ANRS VIHVO vaccine sub-study. (2015) (18)
On the use of magnitude of reduction in HIV-1 RNA in clinical trials: statistical analysis and potential biases. (2002) (18)
The French general population's attitudes toward lockdown against COVID-19: a fragile consensus (2020) (18)
Pneumococcal and influenza vaccination rates in patients treated with corticosteroids and/or immunosuppressive therapies for systemic autoimmune diseases: A cross-sectional study. (2017) (18)
Antibodies Elicited by the Shigella sonnei GMMA Vaccine in Adults Trigger Complement-Mediated Serum Bactericidal Activity: Results From a Phase 1 Dose Escalation Trial Followed by a Booster Extension (2021) (18)
Lessons from a French collaborative case–control study in cystic fibrosis patients during the 2009 A/H1N1 influenza pandemy (2015) (17)
Immunization of HIV-infected adult patients — French recommendations (2016) (17)
Uveitis Associated with Rifabutin Prophylaxis and Itraconazole Therapy (1996) (17)
Immunogenicity and Safety of Beta-Adjuvanted Recombinant Booster Vaccine (2022) (17)
The value of open-source clinical science in pandemic response: lessons from ISARIC (2021) (17)
Barriers and motivations for participation in preventive vaccine clinical trials: Experience of 5 clinical research sites. (2019) (17)
Low influenza vaccination rate among patients with systemic sclerosis. (2010) (17)
CD4+ cell count recovery in naïve patients initiating cART, who achieved and maintained plasma HIV-RNA suppression (2014) (16)
Predictive Factors of Cytomegalovirus Seropositivity among Pregnant Women in Paris, France (2014) (16)
Influence of Environmental Factors on Disease Activity in Spondyloarthritis: A Prospective Cohort Study (2013) (16)
[Epidemiology of HIV-associated malignancies]. (2003) (16)
HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trial (2019) (15)
Persistence of monocyte activation under treatment in people followed since acute HIV-1 infection relative to participants at high or low risk of HIV infection (2020) (14)
Nevirapine or lamivudine plus stavudine and indinavir: examples of 2-class versus 3-class regimens for the treatment of human immunodeficiency virus type 1. (2002) (14)
Vaccine coverage in CF children: A French multicenter study. (2015) (14)
Perspectives for immunotherapy: which applications might achieve an HIV functional cure? (2016) (13)
Immunogenicity and persistence of the 13-valent Pneumococcal Conjugate Vaccine (PCV13) in patients with untreated Smoldering Multiple Myeloma (SMM): A pilot study (2017) (13)
Incidence and predictive biomarkers of Clostridioides difficile infection in hospitalized patients receiving broad-spectrum antibiotics (2021) (13)
Maternal Biochemical Serum Screening for Down Syndrome in Pregnancy With Human Immunodeficiency Virus Infection (2008) (13)
Long-term CD4(+) and CD8(+) T-cell responses induced in HIV-uninfected volunteers following intradermal or intramuscular administration of an HIV-lipopeptide vaccine (ANRS VAC16). (2013) (13)
A French cohort for assessing COVID-19 vaccine responses in specific populations (2021) (13)
Épidémiologie des tumeurs malignes associées à l’infection par le VIH (2003) (13)
Seasonal influenza vaccination of high-risk adults (2016) (13)
Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients (2018) (13)
Immunization during pregnancy (2018) (13)
Antiviral drugs in hospitalized patients with COVID-19 - the DisCoVeRy trial (2021) (13)
Attitudes about COVID-19 Lockdown among General Population, France, March 2020 (2020) (13)
Failure of pneumococcal immunization during remission induction treatment of ANCA-associated vasculitis: The Pneumovas Pilot 1 study. (2017) (12)
A prospective national cohort evaluating ring MVA vaccination as post-exposure prophylaxis for monkeypox (2022) (12)
Validity of self-reported vaccination status among French healthcare students. (2014) (12)
Early antiviral treatment fails to completely prevent herpes-related pain. (2013) (12)
Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013–14: Results from the InNHOVE network (2016) (12)
A population analysis of weight-related differences in lopinavir pharmacokinetics and possible consequences for protease inhibitor-naive and -experienced patients (2009) (12)
Immune activation, smoking, and vaccine response (2017) (12)
Characteristics of human metapneumovirus infection in adults hospitalized for community-acquired influenza-like illness in France, 2012–2018: a retrospective observational study (2020) (12)
Vaccine effectiveness against influenza A(H3N2) and B among laboratory‐confirmed, hospitalised older adults, Europe, 2017‐18: A season of B lineage mismatched to the trivalent vaccine (2020) (12)
Impact de la vaccination de routine de l’enfant contre la varicelle sur l’épidémiologie du zona (2009) (12)
Intention to get vaccinated against COVID-19 among the general population in France: Associated factors and gender disparities (2021) (12)
Influenza epidemiology and influenza vaccine effectiveness during the 2015–2016 season: results from the Global Influenza Hospital Surveillance Network (2019) (12)
State of the art: Could nursing mothers be vaccinated with attenuated live virus vaccine? (2012) (12)
[Influenza infection and pregnancy]. (2013) (12)
Grippe au cours de la grossesse (2013) (12)
Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I study (2022) (12)
Later cART Initiation in Migrant Men from Sub-Saharan Africa without Advanced HIV Disease in France (2015) (12)
Feasibility of Azithromycin Prophylaxis During a Pertussis Outbreak Among Healthcare Workers in a University Hospital in Paris (2006) (11)
Immunogenicity and persistence of a prime-boost re-vaccination strategy for pneumococcal vaccines in patients with rheumatoid arthritis (2018) (11)
Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen (2018) (11)
Impact of body weight on virological and immunological responses to efavirenz-containing regimens in HIV-infected, treatment-naive adults (2015) (11)
Immunogenicity and Safety of 3 Formulations of a Respiratory Syncytial Virus Candidate Vaccine in Nonpregnant Women: A Phase 2, Randomized Trial (2019) (11)
Does the availability of influenza vaccine at prenatal care visits and of immediate vaccination improve vaccination coverage of pregnant women? (2019) (11)
Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials (2013) (11)
A cohort study of enfuvirtide immunological and virological efficacy in clinical practice (2006) (11)
Impact of free on-site vaccine and/or healthcare workers training on hepatitis B vaccination acceptability in high-risk subjects: a pre-post cluster randomized study. (2014) (10)
Term labor management and outcomes in treated HIV‐infected women without contraindications to vaginal delivery and matched controls (2010) (10)
Vaccine Development: From Preclinical Studies to Phase 1/2 Clinical Trials. (2019) (10)
Factors influencing zidovudine efficacy when administered at early stages of Friend virus infection in mice. (1991) (10)
Vaccination against viral hepatitis of HIV-1 infected patients (2012) (10)
Susceptibility of Health Care Students to Measles, Paris, France (2011) (10)
Influenza vaccination of pregnant women in Paris, France: Knowledge, attitudes and practices among midwives (2019) (10)
[Impact of routine pediatric varicella vaccination on the epidemiology of herpes zoster]. (2009) (10)
Opinions et pratiques d’un panel de médecins généralistes français vis-à-vis de la vaccination (2013) (10)
Factors associated with humoral immune response to pandemic A/H1N1(v) 2009 influenza vaccine in cystic fibrosis. (2014) (10)
Factors influencing influenza-vaccination in adults under immunosuppressive therapy for a systemic inflammatory disease. (2009) (10)
Hepatitis C virus-specific cellular immune responses in individuals with no evidence of infection (2012) (10)
Suppression by Thimerosal of Ex-Vivo CD4+ T Cell Response to Influenza Vaccine and Induction of Apoptosis in Primary Memory T Cells (2014) (9)
The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults (2016) (9)
Prévention des infections à papillomavirus et du zona : nouveaux vaccins (2007) (9)
Aide médicale à la procréation chez les personnes infectées par le VIH (2008) (9)
Assessment of SARS-CoV-2 infection by Reverse transcription-PCR and serology in the Paris area: a cross-sectional study (2020) (9)
Severity of self-reported symptoms and psychological burden 6-months after hospital admission for COVID-19: a prospective cohort study (2021) (9)
Long-term persistence of vaccine-induced HIV seropositivity in healthy volunteers. (2014) (9)
Patients with systemic inflammatory and autoimmune diseases are at risk of vaccine-preventable illnesses. (2011) (9)
Vaccination in adult liver transplantation candidates and recipients. (2020) (9)
The value of molecular techniques to diagnose Ureaplasma urealyticum and Nocardia farcinica pleuropneumonia in a patient with diffuse large B-cell lymphoma. (2017) (9)
Prévalence et facteurs de risque de l'hépatite A au sein d'une population de patients infectés par le virus de l'immunodéficience humaine (2005) (8)
Intracytoplasmic sperm injection with microsurgically retrieved spermatozoa in azoospermic men infected with human immunodeficiency virus 1 or hepatitis C virus: the EP43 AZONECO ANRS study. (2013) (8)
Genetic and Antigenic Typing of Seasonal Influenza Virus Breakthrough Cases from a 2008-2009 Vaccine Efficacy Trial (2013) (8)
Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavir. (2011) (8)
Penetration and antiviral efficacy of total and unbound maraviroc, raltegravir and rilpivirine in both female and male genital fluids from HIV-positive patients receiving regimens containing these antiretrovirals (2017) (8)
Are the conditions met to make COVID-19 vaccination mandatory for healthcare professionals? (2021) (8)
Acceptance of childhood and adolescent vaccination against COVID-19 in France: a national cross-sectional study in May 2021 (2021) (8)
Anti-TNFα therapy and vaccination of adults (2007) (8)
[Pregnancy and pandemic influenza A(H1N1) 2009. Current concepts for anaesthesia and critical care medicine]. (2010) (8)
Vaccinations du voyageur adulte transplanté d’organes (à l’exclusion des receveurs de cellules souches hématopoïétiques) (2009) (8)
Grossesse et grippe pandmique A(H1N1) 2009. Actualits pour les anesthsistes ranimateurs (2010) (8)
Conjugate Haemophilus influenzae type b vaccines for sickle cell disease. (2016) (7)
No Positive Association between Vitamin D Level and Immune Responses to Hepatitis B and Streptococcus pneumoniae Vaccination in HIV-Infected Adults (2016) (7)
Public trust on regulatory decisions: The European Medicines Agency and the AstraZeneca COVID-19 vaccine label (2021) (7)
Influence of geographic origin, sex, and HIV transmission group on the outcome of first-line combined antiretroviral therapy in France (2016) (7)
Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II Trial (2020) (7)
Vaccination antivirale des adultes immunodéprimés, revue de la littérature (2008) (7)
First nationwide web-based surveillance system for influenza-like illness in pregnant women: participation and representativeness of the French G-GrippeNet cohort (2016) (7)
Coadministration of seasonal influenza and COVID-19 vaccines: A systematic review of clinical studies (2022) (7)
Pandémie grippale A/H1N1v, grossesse et vaccination (2010) (7)
Vaccine hesitancy among hospital staff physicians: A cross-sectional survey in France in 2019. (2021) (7)
Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history (2010) (7)
Pitfalls in anti-influenza T cell detection by Elispot using thimerosal containing pandemic H1N1 vaccine as antigen. (2012) (6)
Cost-effectiveness of vaccination against cytomegalovirus (CMV) in adolescent girls to prevent infections in pregnant women living in France. (2018) (6)
The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals (2022) (6)
Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis (2016) (6)
[Vaccinations for the traveling adult solid organ transplant recipient (excluding hematopoietic stem cell transplant recipients)]. (2009) (6)
Immunizations in Adult Patients with Systemic Sclerosis (2009) (6)
[Post-exposure vaccination against hepatitis A]. (2005) (6)
Anti-TNFalpha therapy and vaccination of adults. (2007) (6)
Strategies for decision-making on vaccine use: the French experience (2015) (6)
Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19 (2022) (6)
Rougeole et grossesse (2011) (6)
Severe reversible reticulocytopenic anemia associated with quinupristin/dalfopristin RP59500 therapy. (1997) (6)
Immunogenicity and reactogenicity of heterologous and homologous mRNA-1273 and BNT162b2 vaccination: A multicenter non-inferiority randomized trial (2022) (6)
Pharmacokinetics and Diffusion into Sputum of Oseltamivir and Oseltamivir Carboxylate in Adults with Cystic Fibrosis (2011) (6)
Rhinoviruses as an underestimated cause of influenza‐like illness in pregnancy during the 2009–2010 influenza pandemic (2013) (6)
SARS-COV-2 IgG antibody response in pregnant women at delivery (2020) (6)
[Designing an effective AIDS vaccine: strategies and current status]. (2008) (5)
The risk of a swine influenza pandemic: still a concern? (2019) (5)
[Prosthetic valve endocarditis due to Coxiella burnetii: six cases]. (2001) (5)
Effectiveness of seasonal influenza vaccination in patients with diabetes: protocol for a nested case–control study (2017) (5)
Prophylaxie autour d'un cas index d'hépatite A : immunoglobulines ou vaccination ? (2007) (5)
“Real life” use of raltegravir during pregnancy in France: The Coferal-IMEA048 cohort study (2019) (5)
[Assisted procreation technology and people with HIV]. (2008) (5)
Alternative hepatitis B vaccine strategies in healthy non-responders to a first standard vaccination scheme. (2019) (5)
Vaccinations et grossesse (2014) (5)
[Prevalence and risk factors of hepatitis A infection in an HIV-infected French population]. (2005) (5)
COVID-19 Vaccines against Omicron Variant: Real-World Data on Effectiveness (2022) (5)
Memory CD8(+) T cells elicited by HIV-1 lipopeptide vaccines display similar phenotypic profiles but differences in term of magnitude and multifunctionality compared with FLU- or EBV-specific memory T cells in humans. (2014) (5)
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial (2022) (5)
Vaccins pandémiques et prépandémiques dirigés contre le virus grippal H5N1 - État des lieux en 2009 (2009) (5)
Estimating the burden of influenza‐related and associated hospitalizations and deaths in France: An eight‐season data study, 2010–2018 (2021) (5)
How to improve vaccine acceptability (evaluation, pharmacovigilance, communication, public health, mandatory vaccination, fears and beliefs). (2019) (4)
Attitudes, knowledge, and willingness to be vaccinated against seasonal influenza among patients hospitalized with influenza-like-illness: impact of diagnostic testing (2020) (4)
Determinants of measles seroprevalence among pregnant women in Paris, France. (2014) (4)
[Opinions and practices from a panel of French general practitioner doctors regarding vaccination]. (2013) (4)
Intention to vaccinate against influenza among health care workers caring for immunocompromised patients. (2016) (4)
Vaccination antigrippale chez la femme enceinte (2015) (4)
Lamivudine and Indinavir/Ritonavir Maintenance Therapy in Highly Pretreated HIV-Infected Patients (Vista Anrs 109) (2005) (4)
Herpes simplex virus type 2 (HSV-2) genital shedding in HSV-2-/HIV-1-co-infected women receiving effective combination antiretroviral therapy (2016) (4)
Vaccination contre l’hépatite A : autour du cas index (2005) (4)
Pulmonary hoypertension in type 1 Gaucher's disease (1998) (4)
Management of Cytomegalovirus Seroconversion during Pregnancy in France (2015) (4)
Influenza vaccination competence of nurses in France: A survey in nursing schools. (2016) (4)
Do vaccinations affect the clinical course of systemic necrotising vasculitis? A prospective observational web-based study. (2016) (4)
Vaccination des sujets âgés de plus de 65 ans : un enjeu stratégique pour les années futures ! (2013) (4)
[Prophylaxis for contacts of an index case of hepatitis A: immunoglobulins or vaccination?]. (2007) (4)
VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment (2022) (4)
Mise au point d’un vaccin prophylactique contre l’infection par le VIH. Où en est la recherche clinique? (2008) (4)
Vaccinations chez les patients ayant une maladie systémique (2009) (4)
Thérapeutiques antirétrovirales : principes du traitement de l’infection par le VIH (2008) (4)
Multiple sclerosis: Is there a risk of worsening after yellow fever vaccination? (2021) (4)
Does HIV-1 subtype D have a higher risk of vertical transmission than other HIV subtypes? (2009) (4)
Rilpivirine in HIV-1-positive women initiating pregnancy: to switch or not to switch? (2020) (4)
Does enfuvirtide increase the risk of bacterial pneumonia in patients receiving combination antiretroviral therapy? (2010) (4)
Vaccines: specific features, simulation of impact and medico-economic modelling. (2010) (4)
Attitudes towards monkeypox vaccination among healthcare workers in France and Belgium: an element of complacency? (2022) (3)
Augmenter la couverture vaccinale grippe et pneumocoque des populations à risque : le rôle des structures de soins de suite de pneumologie (2013) (3)
Papillomavirus et cancer du col de l'utérus. (2008) (3)
One-month humoral response following two or three doses of messenger RNA coronavirus disease 2019 vaccines as primary vaccination in specific populations in France: first results from the Agence Nationale Recherche contre le Sida (ANRS)0001S COV-POPART cohort (2022) (3)
High heterogeneity on the accepted vaccines for COVID-19 certificates in European countries (2022) (3)
Vaccination de l’adulte : données générales, actualités et perspectives (2017) (3)
Reply to Ogunjimi et al (2012) (3)
Vaccine effectiveness against COVID-19 hospitalization in adults in France: A test negative case control study (2021) (3)
Report of the 2nd "French Clinical Vaccinology Meeting Jean-Gerard Guillet": immunization and respiratory diseases. (2010) (3)
Social and Behavioral Consequences of Participation in HIV Preventive Vaccine Trials in the ANRS COHVAC Cohort (2018) (3)
Is COVID-19 pneumonia differentiable from other viral pneumonia on CT scan? (2021) (3)
Design and content validation of a survey questionnaire assessing the determinants of human papillomavirus (HPV) vaccine hesitancy in France: A reactive Delphi study. (2020) (3)
Maternal influenza immunisation in resource-limited settings. (2016) (3)
Risks of non-vaccination. (2020) (3)
Impact of Sequential Culture Results on Diagnosis and De-Escalation of the Antibiotic Regimen in Joint and Bone Infections. (2017) (3)
Endocardites Coxiella burnetii sur prothse: six observations (2001) (3)
Néphrotoxicité des produits de contraste iodés (1991) (3)
Flexibility of interval between vaccinations with AS03A-adjuvanted influenza A (H1N1) 2009 vaccine in adults aged 18–60 and >60 years: a randomized trial (2012) (3)
T Cell Immunogenicity, Gene Expression Profile, and Safety of Four Heterologous Prime-Boost Combinations of HIV Vaccine Candidates in Healthy Volunteers: Results of the Randomized Multi-Arm Phase I/II ANRS VRI01 Trial (2022) (3)
Immunization Catch-Up for Newly Arrived Migrants in France: A Cross-Sectional Study among French General Practitioners (2021) (3)
Risque d’infections à pneumocoque et prévention vaccinale au cours des maladies systémiques (2009) (3)
Early humoral response to COVID-19 vaccination in patients living with obesity and diabetes in France. The COVPOP OBEDIAB study with results from the ANRS0001S COV-POPART cohort (2023) (2)
in pregnant women in France: Results from a national survey. (2012) (2)
Virological outcomes in ARV-naïve patients switching or not from a first successful boosted PI-regimen to efavirenz, nevirapine or abacavir regimens (2010) (2)
Long-term safety and vaccine-induced seropositivity in healthy volunteers from HIV vaccine trials: a French cohort study. (2019) (2)
Vaccination des patients atteints de mucoviscidose. (2012) (2)
[Avian influenza: vaccines and vaccine politics]. (2008) (2)
[Value of tomodensitometry with injection and late images for the diagnosis of urinary leaks in kidney transplants]. (1992) (2)
Patients’ Perception and Knowledge about Influenza and Pneumococcal Vaccination during the COVID-19 Pandemic: An Online Survey in Patients at Risk of Infections (2021) (2)
A comparison of Sars-Cov-2 vaccine platforms: the CoviCompare project (2022) (2)
A-04 Séroprévalence des virus des hépatites A, B et C et immunogénicité de la vaccination contre les hépatites A et B chez les patients candidats à une transplantation hépatique☆ (2008) (2)
Why should the meningococcal B vaccine be recommended, and therefore reimbursed, for infants in France? (2021) (2)
[Antiviral immunization of immunocompromised adults, literature review]. (2008) (2)
Syndrome de Cushing iatrogène chez une patiente infectée par le VIH : attention à l'interaction corticoïdes inhalés-ritonavir ! (2008) (2)
Patients With Isolated Hepatitis B Core Antibody: Has the Time Come to Vaccinate? (2018) (2)
Attitudes of hospital physicians toward childhood mandatory vaccines in France: A cross-sectional survey (2021) (2)
Pulmonary hypertension in type 1 Gaucher's disease. Comité d'Evaluation du Traitement de la Maladie de Gaucher. (1998) (2)
[Improving the vaccination coverage against influenza and Streptococcus pneumonia in the populations at risk: the role of pulmonary care services]. (2013) (2)
OA04-01. Safety and immunogenicity of LIPO-5, a HIV-1 lipopeptide vaccine: results of ANRS VAC18, a phase 2, randomized, double-blind, placebo-controlled trial (2009) (2)
[Adult immunisation: General points, hot topics and perspectives]. (2017) (2)
What a second booster dose of mRNA COVID-19 vaccines tells us (2022) (2)
Assessment of individual vaccine status in a vaccinology experts' group. (2008) (2)
Heterologous prime boost COVID 19 vaccination (2022) (2)
[Hepatitis B vaccination: a review]. (2015) (2)
Grippe (2020) (2)
[Vaccination and pregnancy]. (2014) (2)
Grippe A/H1N1v : de l’utilité de la vaccination (2010) (2)
An open-label randomized, controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-beta-1a and hydroxychloroquine in hospitalized patients with COVID-19 - Final results from the DisCoVeRy trial (2022) (2)
Attitudes towards a mandatory COVID-19 vaccination in France for the general population or healthcare workers in May 2021 (2021) (2)
Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years (2022) (2)
[Beta-lactamase inhibitors]. (1997) (2)
Replacing vaccine paper package inserts: a multi-country questionnaire study on the acceptability of an electronic replacement in different target groups (2022) (2)
Bacillus Calmette-Guerin infection following intravesical instillation: Does the strain matter? (2019) (2)
Conjugate Haemophilus influenzae type b vaccines for sickle cell disease. (2018) (2)
Immunogenicity and safety results from a randomized multicenter trial comparing a Tdap-IPV vaccine (REPEVAX®) and a tetanus monovalent vaccine in healthy adults (2012) (2)
[Pregnancy: a high risk factor in influenza infection]. (2010) (1)
Vaccination contre le zona (2015) (1)
Hepatitis C virus-specific cellular immune responses in individuals with no evidence of (2012) (1)
Thrombose veineuse jugulaire interne droite chez une jeune femme de 32 ans (1996) (1)
Accelerated phase Ia/b evaluation of the malaria vaccine candidate PfAMA1 DiCo demonstrates broadening of humoral immune responses (2021) (1)
Assisted reproductive technology outcomes in women with a chronic viral disease (2021) (1)
VAC-04 - Echec de la vaccination antipneumococcique en phase d’attaque du traitement des vascularites à ANCA : l’étude pneumovas pilote 1 (2016) (1)
Bacillus Calmette-Guerin vaccine to reduce COVID-19 infections and hospitalisations in healthcare workers: a living systematic review and prospective ALL-IN meta-analysis of individual participant data from randomised controlled trials (2022) (1)
[The vaccination of older adults: a challenge for the future!]. (2013) (1)
[Vaccine effectiveness for seasonal influenza vaccines]. (2016) (1)
Pratiques de rattrapage vaccinal des médecins français pour les personnes migrantes arrivant sur le territoire français (2018) (1)
Re: ‘clinical characteristics of ambulatory and hospitalised patients with monkeypox virus infection’ by Mailhe et al. (2022) (1)
[Antiretroviral therapy: principles for treating HIV infection]. (2008) (1)
Production of TNF-alpha ex vivo is predictive of an immune response to flu vaccination in a frail elderly population (2016) (1)
La vaccination anti-pneumococcique est insuffisamment réalisée chez les patients à risque : à propos de 693 cas d’infections invasives à pneumocoque (2018) (1)
Maternal influenza immunisation to reduce influenza infections and low birthweight in infants in resource-limited countries. (2017) (1)
Faut-il avoir peur de la grippe chez la femme enceinte ? (2010) (1)
Vaccinations chez les patients ayant une cirrhose (2009) (1)
Le VIH... le virus et les personnes infectées prennent de l’âge (2008) (1)
[Pneumococcal infections and vaccination in patients with systemic autoimmune and/or inflammatory diseases]. (2009) (1)
Factors associated with COVID-19 vaccine uptake among French population aged 65 years and older: results from a national online survey (2022) (1)
Réévaluation des carbapénèmes dans la vraie vie : la conformité est-elle médecin-dépendante ? (2017) (1)
[VACCINATION AGAINST HEPATITIS B: WHAT'S UP?]. (2015) (1)
[Quadrivalent influenza vaccine: What is changed and what are the benefits?] (2018) (1)
[Pandemic influenza A/H1N1v, pregnancy and vaccination]. (2010) (1)
Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study (2022) (1)
[Chlamydia pneumoniae infection: an uncommon cause of rhabdomyolysis]. (1996) (1)
K-02 - Variations régionales et déterminants de la couverture vaccinale hépatite B, coqueluche, grippe pandémique et saisonnière des médecins généralistes en France (2013) (1)
Effect of Internet use for searching information on vaccination on the uptake of human papillomavirus vaccine in France: A path-analysis approach. (2021) (1)
State of shock and abdominal pain revealing tamponade caused by rheumatoid arthritis (1994) (1)
Influence of geographic origin on AIDS and serious non-AIDS morbidity/mortality during cART among heterosexual HIV-infected men and women in France (2018) (1)
[Papillomavirus and cervical carcinoma]. (2008) (1)
Health crisis: What opportunities for clinical drug research? (2021) (1)
Chronic use of inhaled corticosteroids in patients admitted for respiratory virus infections: a 6-year prospective multicenter study (2022) (1)
Vaccination contre l’hépatite B (2015) (1)
Vaccination préventive et approches innovantes (2007) (1)
Vaccination préventive et approches innovantes (2007) (1)
Vaccination contre la grippe saisonnière : pour quelle efficacité chez l’adulte ? (2013) (1)
Trivalent-Inactivated Influenza Vaccine Effectiveness Against Hospitalized Influenza in France During 2014–2015 Winter: Results From the FLUVAC Study (2015) (1)
A-09 Vaccinations professionnelles des personnels de santé : état des connaissances (2008) (1)
[Current events in vaccination]. (2011) (1)
Corrigendum to 'A report on the status of vaccination in Europe' [Vaccine 36 (2018) 4979-4992]. (2019) (1)
[Current events in vaccination]. (2011) (1)
Epidemiology and pre-vaccine burden of rotavirus diarrhea in Democratic Republic of Congo (DRC): Results of sentinel surveillance, 2009-2019. (2022) (1)
[Wernicke's encephalopathy in a patient with AIDS]. (2002) (1)
Comment limiter au mieux les risques d’infections au cours du lupus systémique ? (2019) (1)
Online vaccine-related information-seeking in mothers and HPV vaccine uptake in their daughters (2020) (1)
Vaccination antigrippale chez les patients atteints de maladies systémiques inflammatoires et/ou auto-immunes (2011) (1)
Introduction to the First Clinical Vaccinology Meeting "Jean-Gérard Guillet". (2009) (1)
Incidence of PTSD in the French population a month after the COVID-19 pandemic-related lockdown: evidence from a national longitudinal survey (2022) (1)
Symptom‐based case definitions for COVID‐19: Time and geographical variations for detection at hospital admission among 260,000 patients (2022) (1)
[Vaccination of cystic fibrosis patients]. (2012) (1)
Hepatitis C virus-specific cellular immune responses in individuals with no evidence of infection (2012) (1)
[Measles and pregnancy]. (2011) (1)
Chronic use of renin‐angiotensin‐aldosterone system blockers and mortality in COVID‐19: A multicenter prospective cohort and literature review (2021) (1)
Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort (2022) (1)
Chronic use of inhaled corticosteroids in patients admitted for respiratory virus infections: a 6-year prospective multicenter study (2022) (1)
Actualités en matière de vaccination (2011) (1)
Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines (2022) (1)
Intentions to get vaccinated against Monkeypox in Healthcare workers in France and Belgium correlates with attitudes toward COVID-19 vaccination (2022) (1)
AB0322 Evaluation of Vaccines in Rheumatoid Arthritis: Data from the COMORA Study (2014) (1)
Séance bi-académique de l’Académie nationale de médecine et de l’Académie des Sciences: « Confiance et défiance vis-à-vis des vaccins » (2017) (1)
[Iatrogenic Cushing syndrome in an HIV-infected female patient: be careful about interaction inhaled corticosteroids-ritonavir!]. (2008) (1)
Determinants of human papillomavirus (HPV) vaccine uptake among girls in France: A population-based telephone survey (2022) (1)
Immunogénicité et tolérance d’un vaccin grippal quadrivalent à haute dose par rapport à un vaccin grippal quadrivalent à dose standard chez des sujets de 60 ans et plus : un essai randomisé de phase III (2021) (0)
A national platform for Covid-19 vaccine studies recruitment in France: Covireivac volunteer’s characteristics (2022) (0)
Antiretroviral prophylaxis after sexual assault: experience of a medico-legal consultation centre. (2000) (0)
Association between mental disorders and COVID-19 outcomes among inpatients in France: A retrospective nationwide population-based study (2022) (0)
[Meningococcal vaccines in France] (2016) (0)
PRODUCTION OF TNF EX VIVO IS PREDICTIVE OF AN IMMUNE RESPONSE TO FLU VACCINATION IN ELDERLY SUBJECTS (2017) (0)
Guide pratique de vaccination en pneumologie (2020) (0)
Enhancing Public Health Communication Regarding Vaccine Trials: Design and Development of the Pan-European VACCELERATE Toolkit (2022) (0)
A/H3N2 influenza disease (2015) (0)
International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK (2014) (0)
EPH91 Association Between Mental Disorders and COVID-19 Outcomes in Hospitalized Patients in France: A Retrospective Nationwide Population-Based Study (2022) (0)
In-hospital and midterm post-discharge complications of adults hospitalised with respiratory syncytial virus infection in France, 2017–2019: an observational study (2021) (0)
VaccinationCompartments after Inactivated Influenza Effector and Memory Immune Longitudinal and Integrative Biomodeling of (2013) (0)
Pandémie grippale A/H1N1v, grossesse et vaccination Pandemic influenza A/H1N1v, pregnancy and vaccination (2010) (0)
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19 (2022) (0)
[Seasonal influenza vaccination: what expected effect in the adult population?]. (2013) (0)
Vaccination l'hépatite B (2015) (0)
618 HCV-SPECIFIC IMMUNE RESPONSES IN UNINFECTED INDIVIDUALS WITH NO KNOWN RISK FOR HCV EXPOSITION (2008) (0)
[Human papillomavirus vaccination : pharmacovigilance data]. (2020) (0)
142 Immunisation coverage in children with cystic fibrosis: a French multicenter survey (2014) (0)
Respiratory syncytial virus (RSV) disease in hospitalised adults in Europe: comparison of retrospective patient chart reviews of adults =65 (=65y) and (2018) (0)
PIN65 IMPACT OF HERPES ZOSTER AND POSTHERPETIC NEURALGIA ON PATIENTS' QUALITY OF LIFE (2010) (0)
HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trial (2019) (0)
[How to minimize the risk of infection in systemic lupus erythematosus?] (2018) (0)
Production of TNF-alpha ex vivo is predictive of an immune response to flu vaccination in a frail elderly population (2016) (0)
Vaccination post-exposition : mise au point (2017) (0)
[Pandemic and prepandemic H5N1 influenza vaccines: a 2009 update]. (2009) (0)
Reply to the comment of Fayet et al. Obstacles and motivations to influenza and pneumococcal vaccination in patients with rheumatoid arthritis. A qualitative study. (2019) (0)
Fast Determination of Projected Surface Area in Red Blood Cells from Splenectomised Patients with Imaging Flow Cytometry (2017) (0)
Evolution of practices regarding COVID-19 treatment in France during the first wave: results from three cross-sectional surveys (March to June 2020). (2021) (0)
[Vaccination in patients with cirrhosis]. (2009) (0)
INFECTION A CHLAMYDIA PNEUMONIASE : UNE CAUSE EXCEPTIONNELLE DE RHABDOMYOLYSE (1996) (0)
Recommendation of HPV vaccination to boys in France - An unhappy coïncidence with the WHO call to pause the implementation of this vaccination in boys. (2020) (0)
[Atrophic chronic polychondritis relapsing after 33 years remission]. (1994) (0)
[Transient Sjögren syndrome with pancreatic involvement]. (1997) (0)
[Right internal jugular venous thrombosis in a young women 32 years of age]. (1996) (0)
Toxigenic Corynebacterium ulcerans in Woman and Cat (2019) (0)
[More mandatory vaccines, the first step for suppression of obligation: A public health issue]. (2017) (0)
Questions for Biotechs: REIVAC (2011) (0)
Respiratory syncytial virus (RSV) disease in hospitalised adults in Europe with COPD: Impact of GOLD score on RSV disease burden (2018) (0)
Influenza in patients with diabetes and obesity: vaccine effectiveness against hospitalised influenza and complications after hospitalised influenza-like illness (2015) (0)
149* 2009 H1N1 influenza A in cystic fibrosis patients. A French collaborative study (2011) (0)
Iconographies supplémentaires de l'article : Dectin-1 activation unlocks IL12A expression and reveals the T H 1 potency of neonatal dendritic cells (2015) (0)
Decreased ovarian reserve in human immunodeficiency virus infected women: A matched cohort study. (2016) (0)
Waldenström's macroglobulinemia revealed by atypical blood lymphoid cells. (1999) (0)
' s response to reviews Title : Extended antigen sparing potential of AS 03-adjuvanted pandemic H 1 N 1 vaccines in adults and children : Results from two randomised trials (2013) (0)
Influenza immunisation in pregnancy is efficacious and safe, but questions remain. (2020) (0)
[Rectal tuberculosis in HIV patient]. (2015) (0)
Vaccine certificates for international travelers in future pandemics (2022) (0)
Insulin resistance impairs human liver progenitor cell function in vitro: Consequences for liver injury and tumorigenesis in metabolic disease and type 2 diabetes? (2015) (0)
overproduction in response to microbial products α TNF monocytes from viremic HIV-infected patients in + Pivotal role of MDC 8 (2012) (0)
Immunogenicity and safety of the non-typable Haemophilus influenzae–Moraxella catarrhalis (NTHi-Mcat) vaccine administered following the recombinant zoster vaccine versus administration alone: Results from a randomized, phase 2a, non-inferiority trial (2023) (0)
Surveillance post-AMM des vaccins (2005) (0)
[Flu vaccine and auto-immune and/or inflammatory diseases]. (2011) (0)
[Vaccination in patients with systemic diseases]. (2009) (0)
84. One-month Humoral Response Following Two Doses of Covid-19 Vaccines in Specific populations – ANRS0001S COV POPART Cohort Study (2022) (0)
OC 8582 A PHASE IA/B STUDY TO ASSESS SAFETY AND IMMUNOGENICITY OF PLACENTAL MALARIA VACCINE CANDIDATE: PRELIMINARY RESULTS OF THE PRIMALVAC TRIAL (2019) (0)
1610P Humoral immune response to COVID-19 vaccination in patients with cancer: The ANRS0001S COV-POPART study (2022) (0)
Genetic and Antigenic Typing of Seasonal Inﬂuenza Virus Breakthrough Cases from a 2008-2009 Vaccine Efﬁcacy Trial (2014) (0)
Striking differences in weight gain after cART initiation depending on early or advanced presentation: results from the ANRS CO4 FHDH cohort. (2023) (0)
[Vaccine against chickenpox: where are we now?]. (2016) (0)
Safety and Immunogenicity of Hepatitis B Vaccine Regimens in Adults With HIV-1—Reply (2011) (0)
Long-Term Persistence of Vaccine-Induced HIV Seropositivity in Healthy (2014) (0)
Quelle approche pour l’évaluation comparative en situation observationnelle : un exemple dans l’infection à VIH (2011) (0)
Pivotal role of M-DC8 (cid:1) monocytes from viremic HIV-infected patients in TNF (cid:2) overproduction in response to microbial products (2012) (0)
Respiratory Syncytial Virus Infection in Adults Hospitalized with Influenza-like illness in France. (2016) (0)
A 5-year neutralizing immune response to yellow fever vaccine in HIV-infected and HIV-uninfected adults (2022) (0)
The value of public-private collaborative real-world evidence platforms to monitor vaccine performance post authorization: DRIVE - a European initiative (2022) (0)
Outcomes in antiretroviral-naive HIV-infected patients initiating therapy with TDF/FTC plus either atazanavir/r or another third recommended drug (2010) (0)
[New Influenza A H1N1v: usefulness of immunization]. (2010) (0)
[Preventing papillomavirus infectious and herpes zoster: new vaccines]. (2007) (0)
Accelerated phase Ia/b evaluation of the malaria vaccine candidate PfAMA1 DiCo demonstrates broadening of humoral immune responses (2021) (0)
1954. Immunogenicity against SARS CoV-2 ancestral strain and variants of two new COVID-19 recombinant adjuvanted vaccines compared to BNT162b2 as a third dose following two doses of BNT162b2: a single-blinded multicenter randomized controlled trial (2022) (0)
Vaccination of immunocompromised travelers: need for specific recommendations! (2013) (0)
Review for "A comparison of epidemiology and clinical outcomes between influenza A H1N1pdm09 and H3N2 based on multicenter surveillance from 2014 to 2018 in South Korea" (2020) (0)
[Nephrotoxicity of iodine contrast media]. (1987) (0)
PIN72 Burden of Influenza-Related and Associated Hospitalizations in France from Season 2010/11 to 2017/18 (2020) (0)
Sandoval the Growth of Mucosal Tumors T Cells Is Crucial to Inhibit + Mucosal Imprinting of Vaccine-Induced CD 8 (2013) (0)
[Post-licensing surveillance of vaccines]. (2005) (0)
Intention to participate in COVID-19 vaccine clinical trials in May 2021: a cross-sectional survey in the general French population (2022) (0)
Research Project on the Real Effectiveness and Impact of Vaccination Against Rotavirus Diarrhea in DR Congo (2022) (0)
Aide médicale à la procréation et infection par le VIH (2006) (0)
Mise à jour des vaccins en période préconceptionnelle (2016) (0)
Diagnostic d'une fièvre prolongée au décours d'un traitement de rechute de LAM de type 2 (1996) (0)
Les fractures de la charnière dorsolombaire avec paraplégie Frankel A doivent-elles bénéficier d’une chirurgie d’urgence ? À propos de trois cas et revue de la littérature (2012) (0)
N-04: Couverture vaccinale grippe et pneumocoque, connaissances et perception de la vaccination de patients atteints d’un déficit immunitaire secondaire (2014) (0)
Échec de la vaccination antipneumococcique en phase d’attaque du traitement des vascularites à ANCA : l’étude Pneumovas pilote 1 (2017) (0)
Candidémie dans un centre hospitalier universitaire français. Analyse de 58 observations (1989–1995) (1996) (0)
PADS 2-03 - Uvéite syphilitique : étude rétrospective tricentrique de 64 patients (2016) (0)
K-10 - Connaissances, attitudes, perceptions et pratiques des généralistes français vis-à-vis de la rougeole et du ROR (2013) (0)
[Not Available]. (2016) (0)
Couverture vaccinale anti-pneumococcique et anti-grippale chez les patients traités par corticothérapie et/ou immunosuppresseurs pour une maladie auto-immune : étude transversale (2017) (0)
Crise sanitaire : quelles opportunités pour la recherche clinique sur le médicament ? (2021) (0)
Utilisation de spacer en ciment imprégné d’antibiotiques dans la prise en charge des infections de prothèses articulaires (1997) (0)
Incidence de la grippe A(H1N1)v chez les patients infectés par le VIH en France : intérêt d’un réseau clinique spécifique, l’étude 2H de l’Agence nationale de recherches sur le sida et les hépatites virales (ANRS) (2011) (0)
Chapitre X. Les Français et le confinement : un consensus paradoxal ? (2022) (0)
[Vaccination contre le SARS-CoV-2, le Graal ?] (2022) (0)
Harmonisation des pratiques pour la vaccination des adultes atteints de maladie auto-immune et/ou immunodéprimés : résultats d’une enquête Delphi du GEVACCIM (2008) (0)
Traitement anti-TNFα et vaccination de l'adulte (2007) (0)
Vaccination contre la grippe et le pneumocoque chez les malades respiratoires chroniques : carence de couverture vaccinale et d’information (2016) (0)
Syndrome du segment adjacent après arthrodèse cervicale antérieure. Étude rétrospective multicentrique à propos de 288 patients suivis à long terme (2014) (0)
Évolution de la prise en charge thérapeutique du Covid-19 en France : résultats de 3 enquêtes internet successives (2020) (0)
K-08 - Vaccinations de rappel contre la diphtérie, le tétanos, la polio et la coqueluche chez des sujets âgés de 40 ans ou plus n’ayant pas reçu de rappel depuis au moins 20 ans (2013) (0)
Stratégies innovantes de vaccination anti-pneumococcique par rapport au schéma standard chez les patients atteints de vascularites associées aux ANCA recevant du rituximab : essai contrôlé randomisé multicentrique (PNEUMOVAS) (2022) (0)
Vaccins : spécificités, simulation de l’impact et modélisation médico-économique (2010) (0)
Uvéite syphilitique : étude rétrospective tricentrique de 67 patients (2016) (0)
Spondylodiscite à Candida; une complication rare des candidémies (1996) (0)
Voyage en zone à risque en Afrique de l'Est, pour revoir la famille: Commentaires et mise au point sur les vaccins et les voyages du transplanté (2011) (0)
J-04 Immunogénicité de la vaccination contre les hépatites A et B chez les patients candidats à une transplantation hépatique (2009) (0)
N-08: Persistance à long terme des réponses immunologiques après vaccination contre l’hépatite B pour trois catégories d’immunodépression : infection par le VIH, insuffisance rénale chronique et transplantation hépatique (2014) (0)
[Not Available]. (2016) (0)
Caractéristiques des infections à métapneumovirus humain (hMPV) chez des adultes hospitalisés avec un syndrome grippal, France, 2012–2018 (2019) (0)
Faisabilité et efficacité du traitement de l'hépatite Cdans une cohorte de patients co-infectés par le VIH et le VHC (2002) (0)
Complications intra-hospitalières et évolution post-hospitalière des infections à virus respiratoire syncytial chez l’adulte (2020) (0)
PO8 Étude cas-témoin mesurant l’efficacité du vaccin antigrippal saisonnier sur les formes sévères de grippe chez les patients diabétiques ou obèses (2014) (0)
Membres du groupe de travail (2020) (0)
CL021 - Existe-t-il une association entre l’exposition au virus de la varicelle et la survenue d’un zona ? : Étude exposé - non exposé (2010) (0)
Insuffisance aortique aiguë fébrile: penser au diagnostic d'endocardite à Bartonella (1997) (0)
Localisations nodulaires hépatiques de myélome multiple (1997) (0)
Un élargissement des obligations vaccinales pour permettre leur suppression : un enjeu de santé publique ! (2017) (0)
Endocardites à Coxiella burnetii: à propos de cinq observations (1997) (0)
D-24 Tuberculose au cours de l'infection VIH à l'ère des traitements antirétroviraux hautement actifs (2004) (0)
Poster 57 - Pseudo-tumeur inflammatoire hépatique: un diagnostic difficile (1997) (0)
[Not Available]. (2016) (0)
Prise en charge chirurgicale des spondylolyses lombaires multi-étagées : à propos d’un cas et revue de littérature ☆ (2014) (0)
Candidémies chez 13 adultes infectés par le VIH (1996) (0)
Vaccinations : Bases immunologiques, indications, efficacité, complications (2006) (0)
Vaccinations des patients traités par immunosuppresseurs, biothérapie et/ou corticothérapie pour une maladie auto-immune ou inflammatoire chronique (2016) (0)
Vaccination pneumococcique chez les patients atteints de lupus érythémateux systémique : étude multicentrique, randomisée, en double insu, contrôlée (2017) (0)
COL 5-02 - Incidence des syndromes grippaux et couverture vaccinale antigrippale chez les femmes enceintes en France : résultats de l’étude G-GrippeNet (2016) (0)
D-30 Persistance de la seropositivité VIH chez les volontaires non infectés par le VIH ayant participé à un essai vaccinal (2004) (0)
Organisation de la vaccination des patients immunodéprimés dans les centres de santé hospitaliers en France : un champ à investir (2019) (0)
VAC-18 - Évaluation de la perception de l’enseignement de la vaccination auprès des étudiants en médecine français de 6e année (2016) (0)
Facteurs de risques d'infection au cours de la maladie de Wegener: analyse d'une cohorte monocentrique de 94 malades (2006) (0)
Couverture vaccinale, connaissances et pratiques des sages-femmes vis du vaccin contre la grippe (2019) (0)
Intention de vaccination contre la COVID-19 en France (2021) (0)
Titre Hypothese Titre Hypothese Titre Hypothese (2010) (0)
Maladies auto-immunes au cours de l’infection par le VIH : 33 observations (2013) (0)
Qui veut le bien fait le mal (2002) (0)
H-30 Associations d’inhibiteurs de protéase : tolérance et efficacité immunovirologique (2009) (0)
Vaccination COVID-19 : technologies vaccinales, efficacité en vie réelle et spécificités (2022) (0)
Comment améliorer l’acceptabilité vaccinale (évaluation, pharmacovigilance, communication, santé publique, obligation vaccinale, peurs et croyances) (2019) (0)
Réponse au commentaire de Fayet et al. Freins et motivations des patients atteints de polyarthrite rhumatoïde pour la vaccination antigrippale et antipneumococcique : étude qualitative (2020) (0)
[Not Available]. (2010) (0)
Étude rétrospective des infections à virus respiratoire syncytial (VRS) chez l’adulte hospitalisé en Europe (2018) (0)
Procédé de sécurisation d'un objet portatif personnel (2004) (0)
Iconographies supplémentaires de l'article : Vaccinations (2016) (0)
Estimation du fardeau hospitalier direct et attribuable à la grippe en France à partir de la base PMSI (2020) (0)
Uvéite syphilitique : étude rétrospective tricentrique de 64 patients (2016) (0)
Tolérance et immunogénicité du vaccin contre la fièvre jaune chez des patients recevant une corticothérapie systémique : une étude de cohorte observationnelle (2011) (0)
DTPID : comment sont vaccinés les patients atteints d’une maladie inflammatoire systémique ? (2017) (0)
Tuberculose rectale chez un patient infecté par le VIH (2015) (0)
M-40 - Étude de phase I/IIa de VAC-3S : un vaccin immunothérapeutique/immunoprotecteur, en complément des antirétroviraux, au cours de l’infection VIH (2013) (0)
Réseau de surveillance de la couverture vaccinale et des conditions d’immunisation du personnel des établissements de santé : pourquoi, comment (2016) (0)
Pandémie de grippe A (H1N1) 2009 : qu’avons-nous appris ? (2010) (0)
Papillomavirus du col de l'utérus (2008) (0)
Quelles seraient les conditions pour la réalisation d’essais de challenges vaccinaux humains en France ? (2021) (0)
Caractéristiques des volontaires inscrits sur la plateforme nationale dédiée aux essais vaccinaux COVID-19 (2021) (0)
Perception et connaissances des patients à haut risque d'infection sur la vaccination contre la grippe et le pneumocoque pendant la pandémie COVID-19 (2022) (0)
P100 Efficacité du vaccin antigrippal saisonnier sur les hospitalisations liées à la grippe chez les patients diabétiques ou obèses (2015) (0)
Vaccination grippale saisonnière (VGS) et H1N1 (VGH) chez des patients avec maladies auto-immunes et systémiques : étude prospective MAIVAX chez 174 patients (2010) (0)
RESPIR-08 - Facteurs associés à la gravité d’une grippe confirmée chez des adultes hospitalisés en France de 2012 à 2015 : une étude prospective multicentrique (2016) (0)
P2064 Étude pilote cas-témoin mesurant l’efficacité du vaccin antigrippal saisonnier sur les formes sévères de grippe A (H3N2) chez les patients diabétiques ou obèses (2013) (0)
CO-25 – Couverture vaccinale et mucoviscidose pédiatrique: étude multicentrique française (2015) (0)
Vaccin grippal quadrivalent : quels changements pour quels bénéfices ? (2018) (0)
[Not Available]. (2016) (0)
COL4-05 Harmonisation des pratiques pour la vaccination des adultes atteints de maladie auto-immune et/ou traités par thérapeutiques immunosuppressives (2008) (0)
Place actuelle et future des inhibiteurs nucléosidiques de la transcriptase inverse dans la chimiothérapie du VIH (1999) (0)
Vaccins a ARNm : une r evolution technologique (2012) (0)
[Not Available]. (2016) (0)
O76 Syndrome grippal: complications chez les patients diabétiques ou obèses (2015) (0)
Evaluation pharmacologique des thérapeutiques antirétrovirales (2007) (0)
T-07: VAC-3S, un nouveau vaccin immunothérapeutique de l’infection VIH-1 : résultats de la phase I (2014) (0)
CO-02: Syndromes grippaux chez les diabétiques en milieu hospitalier : caractéristiques et complications (2016) (0)
[Not Available]. (2016) (0)
Échec de la vaccination antipneumococcique en phase d’attaque du traitement des vascularites à ANCA : l’étude Pneumovas Pilote 1 (2016) (0)
Vaccination des personnes vivant avec le VIH (2016) (0)
Vaccination des patients ayant un déficit immunitaire héréditaire (2013) (0)
Les vaccins de demain (2017) (0)
Description des patients adultes hospitalisés pour une grippe au cours de l’épidémie 2016–2017 : étude prospective multicentrique FLUVAC (2017) (0)
Qu'est-ce qui peut tomber à l'examen ? (2006) (0)
Grippe aviaire : vaccins et politique vaccinale (2008) (0)
Facteurs associés à la couverture vaccinale contre la grippe et le pneumocoque chez des patients atteints de maladies inflammatoires chroniques de l’intestin (2017) (0)
Impact de la grippe pandémique H1N1 chez les patients atteints de mucoviscidose (2015) (0)
Prophylaxie autour d’un cas index d’hépatite A : immunoglobulines ou vaccination ? ☆ (2008) (0)
N-02 Analyse de la validité du test de dépistage de la trisomie 21 par les marqueurs biochimiques au 2e trimestre de grossesse chez les femmes infectées par le VIH (2008) (0)
Syndrome de Sjögren transitoire avec atteinte pancréatique (1997) (0)
L'infection par le virus de l'immunodéficience humaine chez les migrants d'Afrique subsaharienne analyse des facteurs prédictifs de réponse au traitement antirétroviral (2003) (0)
Immunité humorale à la vaccination Covid-19 en populations particulières : résultats préliminaires de la cohorte ANRS0001 S COV-POPART (2022) (0)
Intérêt de la collaboration entre ophtalmologiste et interniste pour le diagnostic étiologique et le traitement des uvéites: à propos de 32 observations (1997) (0)
Chapitre XI. Une crise politisée ? Masques, chloroquine & vaccin (2022) (0)
Un volontaire aux essais vaccinaux COVID-19 serait-il prêt à participer à un essai clinique vaccinal non COVID-19 ? (2022) (0)
Hypertension artérielle pulmonaire au cours d’une maladie de Gaucher traitée par enzyme de remplacement (1997) (0)
Endocardites infectieuses : description de 90 épisodes sur une période de 18 moisà l'hôpital Bichat-Claude Bernard, et évaluation des facteurs pronostiques (2001) (0)
Efficacité de la vaccination antigrippale saisonnière 2017–2018 chez l’adulte hospitalisé (2018) (0)
Vaccination de l'adulte et transplantation d'organe solide : recommandations générales (2008) (0)
Impact de l’absence d’exposition répétée au virus varicelle-zona (VVZ) sur la fréquence et l’âge de survenue du zona chez l’adulte en France : étude MONA (2011) (0)
COL2-02 Conséquences obstétricales des traitements antirétroviraux à base de lopinavir chez la femme enceinte infectée par le VIH-1 : Etude d’une cohorte monocentrique (2008) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Odile Launay?

Odile Launay is affiliated with the following schools:

Paris Diderot University
Sorbonne University
Université libre de Bruxelles
Université Paris Cité

Odile Launay's Academic­Influence.com Rankings

Odile Launay's Degrees

Why Is Odile Launay Influential?

Odile Launay's Published Works

Published Works

What Schools Are Affiliated With Odile Launay?

Odile Launay's AcademicInfluence.com Rankings